Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 231,274,236 papers from all fields of science
Search
Sign In
Create Free Account
isoginkgetin
Known as:
iso-ginkgetin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Biflavonoids
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Abstract 3325: Ginkgetin, a biflavonoid derived from leaves ofGinkgo biloba, induces autophagic cell death in non-small cell lung cancer via p62
Jian-shu Lou
,
Cathy W. C. Bi
,
Gallant K. L. Chan
,
T. Dong
,
K. Tsim
2017
Corpus ID: 80109112
Chemotherapeutic drugs in the treatment of non-small-cell lung carcinoma (NSCLC) are usually mediated by induction of apoptosis…
Expand
2014
2014
Medicine composition containing isoginkgetin and bilobalide and preparation thereof
吴静
2014
Corpus ID: 102565069
The invention provides a medicine composition containing isoginkgetin and bilobalide and a preparation thereof. The medicine…
Expand
2012
2012
Two new nonacosanetriols from Ginkgo biloba sarcotesta.
Guisheng Zhou
,
Xin Yao
,
+9 authors
J. Duan
Chemistry and Physics of Lipids
2012
Corpus ID: 45331170
2009
2009
Phytochemical Constituents from Metasequoia glyptostroboids Leaves
Chao Duan
,
Jung-Noh Lee
,
C. Lee
,
G. Lee
,
Kun-Kook Lee
2009
Corpus ID: 102059503
【Phytochemical investigation of Metasequoia glyptostroboids leaves resulted in the isolation of ten compounds. The structures…
Expand
2003
2003
Anticancer Drug Comprising Isoginkgetin or Their Pharmaceutically Acceptable Salts as an Active Ingredient
정안식
,
윤상오
,
박수진
,
김애영
,
이호재
2003
Corpus ID: 104273151
PURPOSE: An anticancer drug comprising isoginkgetin or pharmaceutically acceptable salt thereof as an active ingredient is…
Expand
1997
1997
Total Synthesis of Bilobetin and Isoginkgetin
Mao
,
Xs
,
Xu
,
Liang
,
Xt
1997
Corpus ID: 102478988
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE